Cumberland Pharmaceutical... (CPIX)

AI Score

Unlock

4.06

-0.27 (-6.24%)

At close: Mar 27, 2025, 3:59 PM

4.20

3.45%

After-hours: Mar 27, 2025, 06:38 PM EDT

Cumberland Pharmaceuticals Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Revenue	37.87M	39.55M	42.01M	35.99M	37.44M	34.39M	40.74M	41.15M	33.03M	33.52M	36.9M	32.03M	48.85M	51.14M	45.88M	43.54M	35.08M	28.06M	17.82M	10.69M
Cost of Revenue	6.59M	6.07M	9.12M	8.81M	8.65M	7.42M	7.38M	7.37M	5.96M	4.97M	5.05M	5.44M	5.05M	5.36M	3.59M	4.14M	3.05M	2.67M	2.4M	533.26K
Gross Profit	31.28M	33.49M	32.89M	27.17M	28.79M	26.97M	33.36M	33.78M	27.07M	28.55M	31.85M	26.59M	43.81M	45.78M	42.29M	39.4M	32.03M	25.39M	15.42M	10.16M
Operating Income	-6.43M	-6.21M	-5.7M	-7.68M	-6.38M	-9.29M	-7.39M	-4.08M	-1.43M	-1.11M	3.56M	-3.8M	8.82M	9.85M	6.5M	5.78M	7.28M	6.73M	2.22M	749.92K
Interest Income	334.44K	286.85K	98.41K	26.08K	75.34K	243.36K	564.48K	299.33K	204.66K	209.18K	251.45K	230.29K	304.87K	210.73K	200.21K	79.36K	241.28K	382.92K	208.68K	89.24K
Pretax Income	-6.47M	-6.28M	-5.58M	-5.56M	-6.57M	-9.29M	-7.02M	-3.87M	-1.33M	1.25M	3.74M	-3.67M	9.05M	9.71M	5.28M	5.08M	7.31M	6.47M	1.71M	770.32K
Net Income	-6.48M	-6.28M	-5.65M	-5.6M	-6.63M	-9.21M	-6.96M	-7.98M	-944.68K	731.35K	2.42M	-2.1M	5.84M	5.66M	2.46M	3.09M	4.77M	4.04M	4.4M	1.95M
Selling & General & Admin	28.15M	29.1M	26.84M	24.8M	24.96M	25.25M	30.66M	31.52M	23.12M	21.6M	23.3M	23.88M	29.43M	30.14M	30.66M	27.84M	19.53M	14.19M	10.35M	8.24M
Research & Development	4.82M	5.83M	6.69M	5.68M	5.77M	6.87M	7.32M	3.9M	3.19M	3.85M	3.39M	5.62M	5.1M	5.03M	4.33M	4.99M	4.43M	3.69M	2.23M	1.16M
Other Expenses	4.75M	8.1M	5.07M	4.37M	4.43M	4.13M	2.77M	2.44M	2.19M	1.99M	1.6M	896.16K	466.13K	655.3K	686.91K	793.68K	791.11K	783.43K	611.61K	13.49K
Operating Expenses	37.71M	43.04M	38.6M	34.85M	35.17M	36.26M	40.75M	37.86M	28.5M	27.44M	28.29M	30.39M	34.99M	35.93M	35.79M	33.62M	24.75M	18.67M	13.19M	9.41M
Interest Expense	605.51K	667.86K	586K	98.03K	263.63K	246.19K	195.85K	92.9K	106.39K	73.86K	67.07K	103.42K	71.98K	353.5K	1.42M	772.93K	213.3K	639.59K	721.8K	63.2K
Selling & Marketing Expenses	17.02M	18.45M	16.66M	15.02M	14.77M	15.28M	20.26M	21.49M	14.55M	13.99M	14.9M	14.39M	20.33M	20.94M	22.67M	20.19M	14.39M	10.05M	7.35M	5.65M
Cost & Expenses	44.3M	49.11M	47.72M	43.66M	43.82M	43.68M	48.13M	45.23M	34.46M	32.41M	33.34M	35.83M	40.03M	41.29M	39.37M	37.76M	27.79M	21.34M	15.59M	9.94M
Income Tax	-22.67K	45.77K	68.85K	34.89K	55.9K	-79.32K	16.64K	4.17M	-330.92K	575.83K	1.38M	-1.52M	3.24M	4.08M	2.85M	2.02M	2.54M	2.42M	-2.7M	-1.18M
Shares Outstanding (Basic)	14.06M	14.3M	14.56M	14.9M	15.16M	15.4M	15.57M	15.91M	15.74M	16.72M	17.62M	18.33M	19.56M	20.34M	20.33M	14.2M	10.14M	10.03M	9.8M	9.5M
Shares Outstanding (Diluted)	14.06M	14.3M	14.56M	14.9M	15.16M	15.4M	15.61M	15.91M	16.24M	17.09M	17.9M	18.33M	19.79M	20.57M	21.06M	18.23M	16.54M	16.58M	16.45M	16.09M
EPS (Basic)	-0.46	-0.44	-0.39	-0.38	-0.44	-0.6	-0.45	-0.5	-0.06	0.04	0.14	-0.11	0.30	0.28	0.12	0.22	0.47	0.40	0.45	0.21
EPS (Diluted)	-0.46	-0.44	-0.39	-0.38	-0.44	-0.6	-0.45	-0.5	-0.06	0.04	0.14	-0.11	0.30	0.28	0.12	0.17	0.29	0.24	0.27	0.12
EBITDA	-6.43M	153.32K	332.92K	-857.83K	-1.56M	-4.64M	-8.19M	-1.13M	1.17M	3.57M	5.73M	-2.27M	10.02M	11M	7.68M	6.67M	8.31M	7.87M	3.02M	882.39K
Depreciation & Amortization	6.04M	5.77M	5.33M	4.61M	4.75M	4.4M	2.98M	2.65M	2.4M	2.25M	1.99M	1.3M	901.65K	1.04M	978.4K	816.5K	786.6K	762.22K	587.74K	53.54K